Bioscience

Biozona Weekly: TGen research; Biomarker approval; Commercialization course

March 28, 2014

By Flinn Foundation

Go inside our Reporter’s Notebook event featuring Mayo Clinic CEO Wyatt Decker
3/27/14 | Phoenix Business Journal | Angela Gonzales

Mayo Clinic CEO Dr. Wyatt Decker was the first guest of the Phoenix Business Journal’s new series, “Inside the Reporter’s Notebook,” where he was interviewed for about an hour in front of about 50 business executives.

TGen case study reveals benefits of clinical tumor sequencing, complexities of cancer

3/26/14 | Genome Web | Monica Heger

Translational Genomics Research Institute sequenced the whole genome of a patient with a rare and very aggressive type of thyroid cancer and identified a target for which there is an approved drug available, an example of how whole-genome sequencing can provide critical information to guide the care of cancer patients.

New UA management course a how-to on taking inventions to market

3/25/14 | Arizona Daily Star | Ashley Powell

Technology, Entrepreneurship and Commercialization, a graduate-level course at the Eller College of Management at the University of Arizona, serves as a bridge to connect inventors to their products’ commercialization.

Researcher combines art, science in cancer spread study

3/25/14 | Arizona Public Media | Georgia Davis

UA assistant professor of cellular and molecular medicine, Ghassan Mouneimne, Ph.D., uses microscopes and Photoshop to create startling–and even beautiful to some–images of cancer cells not to beautify cancer, but rather to provide a different perspective.

UA College of Medicine-Phoenix neurologist’s studies at center of FDA approval of biomarkers for Alzheimer’s testing

3/24/14 | Phoenix Business Journal | Staff Report

A University of Arizona College of Medicine-Phoenix neurologist oversaw the trials of a product that received approval by the U.S. Food and Drug Administration as a biomarker for Alzheimer’s testing.  

Tallwave pumps more than $500,000 into business competitions, trio of startups
3/24/14 | Phoenix Business Journal | Hayley Ringle

Scottsdale-based Tallwave Capital has invested more than $500,000 in two business competitions and three early-stage venture finalists to help commercialize their businesses.

Phoenix institute makes stride in ovarian cancer research

3/23/14 | Arizona Republic | Ken Alltucker

TGen said it has identified a molecular protein that is often absent in a rare type of ovarian cancer that strikes young women, which may be a useful tool to diagnose and potentially test drugs to treat the disease.

University of Arizona seeks to decrease disparities in health care
3/23/14 | Arizona Capitol Times | Guest Opinion (Joe G.N. “Skip” Garcia)

As our state and nation confront a rapidly changing U.S. health care system, the University of Arizona is responding to critical challenges in new and impactful ways, including addressing health disparities, improving the health of populations and achieving favorable health outcomes.